Merck & Co is set to exit the genomic services and cancer diagnostics provider in an acquisition by Bio-Techne potentially sized at $320m.

Du, MBC and Mobily are set to exit the music streaming platform operator as it agrees to list through a reverse takeover.

The financial planning technology developer has been bought by MoneyLion just over a year after raising money from NFP Global.

Salesforce Ventures, NTT Docomo Ventures, DTCP and Telstra Ventures are set to exit the authentication technology developer in an all-stock transaction.

SoftBank and existing Doma investor Lennar are contributing to a $300m PIPE deal that will support the property transaction technology provider's reverse merger.

The Mitsui and Intel-backed cloud video platform developer has filed to go public having last raised money five years ago.

SoftBank Vision Fund had provided $1.45bn of funding for the supply chain financier, which is reportedly preparing for insolvency.

OneTrust has acquired DocuVision, providing exits to investors including Berkeley SkyDeck Fund and Oxford Seed Fund.

Susquehanna International Group looks set to exit the microbiome therapeutics developer, which has filed to raise up to $100m in its initial public offering.

Pfizer Ventures could be in line for an exit after AbbVie purchased a buyout option for Parkinson's disease drug developer Mitokinin.